Related Experiment Video
Updated: Jul 11, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Coiled-coil domain containing 85B suppresses the beta-catenin activity in a p53-dependent manner
A Iwai1, M Hijikata, T Hishiki
1Division of Gastroenterology and Hepatology, Department of Medicine, Kyoto University, Kyoto, Japan.
Abstract:
Aberrant accumulation of beta-catenin is closely related to carcinogenesis. Mutations in the p53 gene are reported to induce the aberrant accumulation of beta-catenin in the absence of dysfunction in the glycogen synthase kinase 3beta (GSK3beta)-mediated degradation pathway, but the mechanism remains incompletely understood. Here, we show that human coiled-coil domain containing 85B (CCDC85B) is induced by p53 and regulates beta-catenin activity via interaction with the T-cell factor 4 in the nucleus. Moreover, CCDC85B enhances the degradation of beta-catenin and suppresses tumor cell growth. In conclusion, we revealed that CCDC85B-induced degradation of beta-catenin is independent of GSK3beta and other p53-inducible products, Siah-1L, suggesting that CCDC85B constitutes the one of the frameworks of p53-induced multiple regulatory pathways for beta-catenin activity.
Insights
p53-induced CCDC85B protein degrades beta-catenin, independent of GSK3beta, suppressing tumor growth. This reveals a novel p53 pathway regulating beta-catenin activity in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Aberrant beta-catenin accumulation is a hallmark of carcinogenesis.
- p53 gene mutations can lead to beta-catenin accumulation independently of the GSK3beta pathway, but the mechanism is unclear.
Purpose of the Study:
- To investigate the role of human coiled-coil domain containing 85B (CCDC85B) in regulating beta-catenin activity.
- To elucidate the mechanism by which p53 influences beta-catenin levels.
Main Methods:
- Investigated the interaction between CCDC85B and T-cell factor 4 (TCF4) in the nucleus.
- Assessed the effect of CCDC85B on beta-catenin degradation.
- Evaluated the impact of CCDC85B on tumor cell growth.
Main Results:
- CCDC85B is induced by p53.
- CCDC85B interacts with TCF4 in the nucleus, regulating beta-catenin.
- CCDC85B enhances beta-catenin degradation and suppresses tumor cell proliferation.
- CCDC85B-mediated beta-catenin degradation is independent of GSK3beta and Siah-1L.
Conclusions:
- CCDC85B is a novel p53-inducible protein that regulates beta-catenin.
- CCDC85B promotes beta-catenin degradation through a GSK3beta-independent mechanism.
- CCDC85B represents a component of p53-mediated regulatory pathways controlling beta-catenin in cancer development.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Abnormal Proliferation
Negative Regulator Molecules
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

